After PRF therapy, the increase in SERT density and the SUR of 4-[18F]-ADAM in the striatum and thalamus paralleled the improvement of pain and depression-like behaviors, suggesting that immediate PRF therapy after SNI provides long-lasting protection against SNI-induced SERT reduction. The gene discussed is SLC6A4; the disease is depressive symptom measurement.